Two-year follow-up data from 34 subjects in the VenoValve pivotal trial show sustained clinical improvement and continued patient benefit, from 12 months to 24 months.

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

Sango Rota lies in ruins, a lakeside village that bears the scars of nature's fury. Precariously hanging mud houses threaten ...

Aesthetic counter-tops in high-end kitchen spaces are bound to make you feel tempted to invest in one but you might want to reconsider after knowing the plight of those who suffer from a fatal lung di ...